Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00921_DB01037> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00921_DB01037 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00921_DB01037 label "DDI between Buprenorphine and Selegiline - Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors like selegiline. When possible, avoid use of buprenorphine in patients who have used a monoamine oxidase inhibitor within the past 14 days due to possible severe adverse effects. [drugbank_resource:DB00921_DB01037]" assertion.
- drugbank_resource:DB00921_DB01037 identifier "drugbank_resource:DB00921_DB01037" assertion.
- drugbank_resource:DB00921_DB01037 title "DDI between Buprenorphine and Selegiline - Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors like selegiline. When possible, avoid use of buprenorphine in patients who have used a monoamine oxidase inhibitor within the past 14 days due to possible severe adverse effects." assertion.